Brief: Emcure Pharmaceuticals Sept-Quarter Consol Net Profit 1.95 Bln Rupees
07/11/2024 10:19
Nov 7 (Reuters) - Emcure Pharmaceuticals Ltd EMCU.NS :
* SEPT-QUARTER CONSOL NET PROFIT 1.95 BILLION RUPEES
* SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 20.02
BILLION RUPEES
Source text: ID:nNSE517drk
Further company coverage: EMCU.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees